Navigation Links
Drug May Stem Slide Into Alzheimer's for Some
Date:6/15/2009

Aricept did not help others with mild memory loss, study finds,,

MONDAY, June 15 (HealthDay News) -- Depression might increase the chance of developing Alzheimer's disease among those already experiencing memory problems, a new study says.

But the drug donepezil (Aricept), commonly prescribed for people with Alzheimer's, could slow the depressed person's slide into the disease, the study also found.

The findings are reported in the June 16 issue of Neurology.

"Our longer-term findings add to the body of evidence that suggests depression is a major risk factor for Alzheimer's disease," study author Po H. Lu, an assistant professor of neurology at the David Geffen School of Medicine at the University of California, Los Angeles, said in a news release from the American Academy of Neurology.

The researchers' conclusions stemmed from a three-year study of 756 middle-aged and older people diagnosed with mild cognitive impairment, in which the memory is worse than would be expected at a given age but who otherwise show no signs of Alzheimer's disease.

Based on a test to measure depressive symptoms, the researchers found that the more depressed people were, the greater their chance of developing Alzheimer's.

During the study period, participants took either vitamin E, donepezil or a placebo. After about two years, 14 percent of those diagnosed with depression who took donepezil had developed Alzheimer's, compared with 29 percent of those who took either the vitamin or placebo. Donepezil had little effect in the group of people who were not depressed, according to the study.

"If we can delay the progression of this disease for even two years, it could significantly improve the quality of life for many people dealing with memory loss," Lu said.

Donepezil can help control symptoms of people with mild to severe Alzheimer's disease, but it is not approved in the United States as a treatment for mild cognitive impairment.

More information

The Alzheimer's Association has more about Alzheimer's disease.



-- Kevin McKeever



SOURCE: American Academy of Neurology, news release, June 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. OrthoSynetics Selects Landslides Sales P3 System as its Corporate Sales System
2. IOF launches educational slide kit to enhance understanding of FRAX
3. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
4. CRis New Vectra(TM) Platform Rapidly Analyzes Tissue Slides and Microarrays in Brightfield and Fluorescence
5. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
6. Cardiovascular Disease and Diabetes: New Blog and Slide Presentation on the Diabetes Best Practices Website Discuss the Most Recent Studies in this Field
7. Expert: Long-term care health coverage a hidden casualty of economic slide
8. Head-First Slide a Heads-Up Play
9. Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience
10. Angioslide Closes US$8.6million Series C Financing
11. Wired, Working Americans Let Nighttime Health Routines Slide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Stem Slide Into Alzheimer's for Some 
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... fat (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 ... its adipose filtration technology. The '398 and '324 patents cover methods and ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... solution focused on delivering end-to-end sleep health care at scale, indicates record-breaking ... shows that adherence rates for positive airway pressure (PAP) therapy, the most widely ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating clubfoot as ... 100,000 children in their treatment program. Clubfoot is a pervasive problem in the ... is limited or non-existent. Without intervention, these children are destined to grow up ...
(Date:7/24/2017)... ... 24, 2017 , ... On July 19th, the Chinese Academy ... the awarding ceremony was held successfully in Beijing. The State Health Planning Commission, ... system, and national Chinese medicine experts also attended the event, including more than ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... , July 5, 2017 Pace Analytical, a company of over 2,000 ... that they have acquired ESC Lab Sciences, further solidifying their position as the ... States . ... Vanderboom- President and CEO of Pace Analytical ... Lab Sciences out of Mt Juliet, TN , enhances Pace ...
Breaking Medicine Technology: